Generated November 3, 2026 at 4:38 PM ET
· Covers November 3 trading day
· 10 of 341 ready 8-Ks selected
· AI-assisted overview
The selected 8-K filings included MarineMax saying all regulatory approvals and waiting periods for its merger with SHM Holdco and Intrepid are complete, with a shareholder vote set for November 11 and closing expected by end of calendar 2026. Braemar Hotels & Resorts closed the $372.0 million sale of the Four Seasons Scottsdale, while DigitalOcean reported Q3 revenue of $321 million, up 40%, and launched a $1 billion ATM, and Supermicro reported Q1 FY27 net sales of $19.9 billion with Q2 guidance of $19.5 billion to $21.5 billion. Driven Brands said it will restate FY2023 through FY2025 and quarterly results through Q2 2026 due to fixed-asset errors, cut its FY26 EBITDA guide, delayed its Q3 filing, and suspended share repurchases. OppFi withdrew its OCC, Federal Reserve, and FDIC applications for the BNCCORP deal while saying the merger agreement remains in effect; Regis shareholders rejected five of six director nominees and EVP Jamie Suarez is exiting; and Acura Pharmaceuticals disclosed new borrowings and a going-concern warning. SeaStar Medical said the FDA confirmed its QUELIMMUNE registry met post-approval requirements, and Camber Energy's filing said Viking Global's VKIN-300 received a French LNE Attestation of Conformity valid through October 2031.
leadership
negative
materiality 0.68
November 3, 2026, 4:05 PM ET
Regis shareholders reject 5 of 6 director nominees and say-on-pay; EVP Jamie Suarez exits
- EVP Company Operations Jamie Suarez loses officer role effective Oct 30, 2026; employment ends Nov 22, 2026 with severance under the amended senior executive severance policy.
- Andrews (353,693 for / 1,085,118 against), Benacci (355,843 / 1,082,977) and Mansbach (355,875 / 1,082,840) failed majority votes at the Oct 28, 2026 annual meeting.
- Alfano (679,755 for / 759,046 against) and Lintonsmith (540,911 / 912,785) also fell short; only William Charters was elected, 1,415,415 for vs 36,005 against.
M&A
negative
materiality 0.65
November 3, 2026, 8:36 AM ET
OppFi withdraws OCC, Fed, FDIC applications for BNCCORP deal; merger agreement remains in effect
- OppFi withdrew applications to the OCC, Federal Reserve and FDIC for its proposed acquisition of BNCCORP (OTCQX: BNCC) and BNC National Bank.
- Merger agreement dated April 28, 2026 has not been terminated and remains in effect, OppFi said.
- OppFi reaffirmed 2026 guidance: revenue $600M-$610M, adjusted net income $115M-$120M, adjusted EPS $1.34-$1.40 on ~86M diluted shares.
M&A
positive
materiality 0.90
November 3, 2026, 4:05 PM ET
MarineMax clears all regulatory approvals for Safe Harbor Marinas/Blackstone merger
- All regulatory approvals and waiting periods for MarineMax's merger with SHM Holdco and Intrepid are complete as of October 31, 2026.
- Shareholders will vote on the merger agreement at a special meeting scheduled for November 11, 2026.
- MarineMax expects closing by end of calendar 2026; closing cannot occur before December 7, 2026 without Parent's written consent.
BHR
Braemar Hotels & Resorts Inc.
M&A
positive
materiality 0.80
November 3, 2026, 4:04 PM ET
Braemar closes $372M sale of Four Seasons Scottsdale at 5.8% cap rate, 15.0x EBITDA
- Sold 210-room Four Seasons Resort Scottsdale to Evergreen Acquisitions for $372.0M cash ($1.8M/key); 5.8% cap rate and 15.0x trailing-12M Hotel EBITDA after $23M anticipated capex.
- Received ~$370.1M net of selling expenses and repaid ~$180.0M on the hotel mortgage; proceeds plus cash on hand to fund remaining external-advisor separation fees.
- CEO Richard J. Stockton said the 2022 acquisition generated an ~15% unlevered return, above the 10% minimum target; self-managed REIT transition on track for mid-November 2026.
ICU
SeaStar Medical Holding Corp
regulatory
positive
materiality 0.72
November 3, 2026, 8:30 AM ET
FDA Confirms SeaStar Medical's QUELIMMUNE SAVE Registry Fulfilled Post-Approval Requirements
- FDA's CBER determined the QUELIMMUNE Pediatric SAVE Surveillance Registry met post-approval study requirements under the original Humanitarian Device Exemption.
- SAVE Registry data showed 90-day survival of 65.1% for QUELIMMUNE patients (N=43) versus 47.5% for KID cohorts (N=196), P=0.043.
- Registry patients showed no device-related adverse events; results were presented as a late-breaker at ASN Kidney Week 2026.
regulatory
positive
materiality 0.65
November 3, 2026, 8:39 AM ET
Viking Global's VKIN-300 wins French LNE Attestation of Conformity No. 41506-0, valid to Oct 2031
- LNE issued Attestation No. 41506-0 on Oct 28, 2026 for the VKIN 300 SD ozone-based medical waste unit; valid through Oct 27, 2031 and renewable only once.
- Certified parameters: minimum average ozone concentration of 3,500 ppm per 45-minute cycle; Viking Ozone Technology, LLC is attestation holder, BOX 03 SARL its French representative.
- Follows the Sept 15, 2026 French amendment adopting standard NF X 30-503-1:2024; LNE evaluation report P255031/1 found biological-indicator and infectious-waste tests satisfactory.
—
ACURA PHARMACEUTICALS, INC
debt
negative
materiality 0.82
November 3, 2026, 8:20 AM ET
Acura Pharmaceuticals borrows $141,607 from AD Pharma; note balance hits $11.44M with going-concern warning
- Two new loans of $41,607 (Oct 19, 2026) and $100,000 (Oct 30, 2026) from Abuse Deterrent Pharma bring the secured note principal to $11,435,886.
- Accrued interest is approximately $1,416,000 as of October 31, 2026; the note bears 5.25% interest, rising to 7.5% on overdue amounts.
- Acura says without additional financing by late-November 2026 it must furlough or lay off employees, terminate operations, or seek bankruptcy protection.
DOCN
DigitalOcean Holdings, Inc.
earnings
positive
materiality 0.88
November 3, 2026, 8:18 AM ET
DigitalOcean Q3 revenue $321M, up 40%; guides Q4 growth 44-45% and 2027 60%+; launches $1B ATM
- Q3 revenue $321M, up 40% YoY; ARR $1,285M (+40%); record $160M incremental ARR (+266%); AI Customer ARR $376M, up 288% YoY.
- Net loss $43M (13% margin); diluted EPS -$0.37 and non-GAAP diluted EPS $0.45, which excludes $0.46 hit from $57M induced conversion on $472M of 2030 convertible notes repurchased.
- Adjusted EBITDA $144M (45% margin, +45%); operating income $33M (10%); adjusted operating income $74M (23%); operating cash flow $161M (50% margin); adjusted FCF $130M (41%).
SMCI
Super Micro Computer, Inc.
earnings
positive
materiality 0.85
November 3, 2026, 4:31 PM ET
Supermicro Q1 FY27 net sales $19.9B vs $5.0B a year ago; diluted EPS $1.75, Q2 guide $19.5-21.5B
- Net sales $19.9B vs $5.0B in Q1 FY26 and $11.1B in Q4 FY26; GAAP gross margin 12.7% vs 17.5% QoQ and 9.3% YoY.
- Net income $1,594M vs $168M a year ago; diluted EPS $1.75 vs $0.26; non-GAAP diluted EPS $1.81 on non-GAAP gross margin of 12.8%.
- Q2 FY27 outlook: net sales $19.5-21.5B, GAAP EPS $1.59-1.83, non-GAAP EPS $1.66-1.90; full FY27 net sales guided to $72.0-82.0B.
DRVN
Driven Brands Holdings Inc.
other material
negative
materiality 0.90
November 3, 2026, 8:08 AM ET
Driven Brands to restate FY2023-2025 results on fixed-asset errors; cuts FY26 EBITDA guide to $410-430M
- Audit Committee concluded Oct 31, 2026 that FY2023, FY2024, FY2025 and quarterly results through Q2 2026 contain material errors; PwC's audit report can no longer be relied upon.
- Errors tied to fixed assets: failure to timely write off sale-leaseback assets, misclassification and incorrect useful lives; CFO Mike Diamond says Adjusted EBITDA impact is negligible to date.
- Q3 Form 10-Q will miss the Nov 5, 2026 deadline; Form 12b-25 due by Nov 6, Q3 earnings call delayed, and share repurchases suspended until reporting is current.